利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

35 条记录 (耗时 0.026 秒)

    DIALYSIS PRECURSOR COMPOSITION
    11.
    发明申请
    DIALYSIS PRECURSOR COMPOSITION 审中-公开
    DIALYSIS前身组成

    公开(公告)号：US20130183389A1

    公开(公告)日：2013-07-18

    申请号：US13805040

    申请日：2011-06-20

    申请人： Ola Carlsson ,  Torbjorn Linden ,  Lennart Jonsson ,  Anders Wieslander

    发明人： Ola Carlsson ,  Torbjorn Linden ,  Lennart Jonsson ,  Anders Wieslander

    IPC分类号： A61K33/14

    CPC分类号： A61K33/14 ,  A61K9/0029 ,  A61K9/0095 ,  A61K31/19 ,  A61K31/191 ,  A61K31/194 ,  A61K31/198 ,  A61K31/366 ,  A61K31/385 ,  A61K31/7004 ,  A61K33/00 ,  A61K33/06 ,  A61M1/287 ,  A61K2300/00

    摘要： The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consist of powder components comprising sodium chloride, at least one dry acid and at least one magnesium salt, and optionally potassium salt, calcium salt, and glucose. According to the invention said at least one magnesium salt and said optional glucose, are present as anhydrous components in said dialysis acid precursor composition.

    摘要翻译： 本发明涉及一种透析酸前体组合物，用于制备透析酸浓缩液，并与水和含碳酸氢盐的浓缩液混合成即用型透析溶液。 所述透析酸前体组合物由包含氯化钠，至少一种干酸和至少一种镁盐，以及任选的钾盐，钙盐和葡萄糖的粉末组分组成。 根据本发明，所述至少一种镁盐和所述任选的葡萄糖以所述透析酸前体组合物中的无水组分存在。

    Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
    16.
    发明申请
    Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis 审中-公开
    制备用于腹膜透析的药物的药液的制备方法

    公开(公告)号：US20060046975A1

    公开(公告)日：2006-03-02

    申请号：US10538791

    申请日：2003-12-10

    申请人： Ola Carlsson ,  Torbjorn Linden ,  Anders Wieslander

    发明人： Ola Carlsson ,  Torbjorn Linden ,  Anders Wieslander

    IPC分类号： C13F3/00 ,  A61K31/70

    CPC分类号： A61M1/287 ,  A61K31/7008 ,  A61K31/722 ,  A61K31/726

    摘要： A method for preparing a medical solution, comprising the steps of a) providing a solution comprising one or more acetylated or deacetylated amino sugar/sugars in at least one compartment of a container in a concentration from 15% by weight to 40% by weight, with the basis of the solution in said at least one compartments, and b) terminal sterilisation of said at least one compartment and the contents therein, is disclosed, as well as a solution used for preparing the medical solution, a container containing said solution, and use of said solution for the manufacture of a medicament for peritoneal dialysis.

    摘要翻译： 一种制备医用溶液的方法，包括以下步骤：a）在容器的至少一个室中提供浓度为15重量％至40重量％的一种或多种乙酰化或脱乙酰氨基糖/糖的溶液， 其中所述至少一个隔室中的溶液的基础，以及b）所述至少一个隔室及其中的内容物的末端灭菌，以及用于制备医用溶液的溶液，容纳所述溶液的容器， 以及使用所述溶液制造用于腹膜透析的药物。

    CONTROLLING AN APPARATUS FOR FLUID TRANSFER TO AND/OR FROM A SUBJECT
    17.
    发明申请
    CONTROLLING AN APPARATUS FOR FLUID TRANSFER TO AND/OR FROM A SUBJECT 有权
    控制流体转移到和/或从主体的流体装置

    公开(公告)号：US20130172803A1

    公开(公告)日：2013-07-04

    申请号：US13519148

    申请日：2010-12-22

    申请人： Bo Olde ,  Kristian Solem ,  Thomas Hertz ,  Jan Sternby ,  Anders Wieslander

    发明人： Bo Olde ,  Kristian Solem ,  Thomas Hertz ,  Jan Sternby ,  Anders Wieslander

    IPC分类号： A61M1/30

    CPC分类号： A61M1/3656 ,  A61B5/02125 ,  A61B5/0215 ,  A61B5/02405 ,  A61B5/4836 ,  A61M1/30 ,  A61M1/3643 ,  A61M1/3644 ,  A61M1/3653 ,  A61M1/3659 ,  A61M2205/3331 ,  A61M2205/6018

    摘要： A control system (23) is arranged to control the operation of an apparatus (200) for extracorporeal blood treatment. The apparatus (200) comprises an extracorporeal blood circuit (20) and a connection system (C) for connecting the blood circuit (20) to the vascular system of a patient. The blood circuit (20) comprises a blood processing device (6), and at least one pumping device (3). The control system is operable to switch between a pre-treatment mode and a blood treatment mode. The blood treatment mode involves operating the blood circuit (20) to pump blood from the vascular system via the connection system (C) through the blood processing device (6) and back to the vascular system via the connection system (C). The control system (23) is operable to obtain measurement data from at least one energy transfer sensor (40) arranged to sense a transfer of energy between the patient and the connection system (C) or between the patient and the blood circuit (20). The control system (23) is configured to, in the pre-treatment mode, process the measurement data for identification of a characteristic change indicating a connection of the blood circuit (20) to the vascular system of the patient, and, upon such identification, take dedicated action. The action may involve activating at least part of a patient protection system and/or enabling entry into the blood treatment mode. The control system may be included in an apparatus (200) for blood treatment, such as a dialysis machine.

    摘要翻译： 控制系统（23）被布置成控制用于体外血液处理的装置（200）的操作。 装置（200）包括用于将血液回路（20）连接到患者血管系统的体外血液回路（20）和连接系统（C）。 血液回路（20）包括血液处理装置（6）和至少一个泵送装置（3）。 控制系统可操作以在预处理模式和血液处理模式之间切换。 血液处理模式包括操作血液回路（20），以经由连接系统（C）从血管系统通过血液处理装置（6）泵送血液，并通过连接系统（C）返回血管系统。 控制系统（23）可操作以从至少一个能量传递传感器（40）获得测量数据，所述能量传递传感器（40）布置成感测患者和连接系统（C）之间或患者与血液回路（20）之间的能量传递， 。 控制系统（23）被配置为在预处理模式下处理用于识别指示血液回路（20）与患者的血管系统的连接的特征变化的测量数据，并且在这种识别 ，采取专门的行动。 该动作可以涉及激活患者保护系统的至少一部分和/或使得能够进入血液处理模式。 控制系统可以包括在用于血液处理的装置（200）中，例如透析机。

    DIALYSIS PRECURSOR COMPOSITION
    19.
    发明申请
    DIALYSIS PRECURSOR COMPOSITION 有权
    DIALYSIS前身组成

    公开(公告)号：US20140225033A1

    公开(公告)日：2014-08-14

    申请号：US14128375

    申请日：2012-06-11

    申请人： Olof Jansson ,  Torbjorn Linden ,  Anders Wieslander

    发明人： Olof Jansson ,  Torbjorn Linden ,  Anders Wieslander

    IPC分类号： A61M1/16 ,  B65B29/06 ,  B65B1/00

    CPC分类号： A61K33/10 ,  A61K9/0029 ,  A61K9/0095 ,  A61K9/08 ,  A61K31/185 ,  A61K31/194 ,  A61K31/7004 ,  A61K33/14 ,  A61M1/1654 ,  B65B1/00 ,  B65B29/06 ,  A61K2300/00

    摘要： The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consists of powder components comprising sodium chloride, at least one dry acid and at least one calcium salt, and optionally potassium salt, magnesium salt, and glucose. According to the invention said at least one calcium salt and said optional glucose, are present as anhydrous components in said dialysis acid precursor composition.

    摘要翻译： 本发明涉及一种透析酸前体组合物，用于制备透析酸浓缩液，并与水和含碳酸氢盐的浓缩液混合成即用型透析溶液。 所述透析酸前体组合物由包含氯化钠，至少一种干酸和至少一种钙盐，以及任选的钾盐，镁盐和葡萄糖的粉末组分组成。 根据本发明，所述至少一种钙盐和任选的葡萄糖以所述透析酸前体组合物中的无水组分存在。

    AMBULATORY ULTRAFILTRATION DEVICE, RELATED METHODS AND A COMPUTER PROGRAM PRODUCT
    20.
    发明申请
    AMBULATORY ULTRAFILTRATION DEVICE, RELATED METHODS AND A COMPUTER PROGRAM PRODUCT 有权
    强制超声波装置，相关方法和计算机程序产品

    公开(公告)号：US20130228516A1

    公开(公告)日：2013-09-05

    申请号：US13808770

    申请日：2011-06-16

    申请人： Lennart Jonsson ,  Jan Sternby ,  Anders Wieslander

    发明人： Lennart Jonsson ,  Jan Sternby ,  Anders Wieslander

    IPC分类号： A61M1/30

    CPC分类号： A61M1/30 ,  A61M1/302 ,  A61M1/303 ,  A61M1/3427 ,  A61M1/3604 ,  A61M1/365 ,  A61M1/3672 ,  A61M2209/088

    摘要： An ambulatory ultrafiltration device includes a blood filter that has a blood side or fluid communication with the vascular system of the subject, an ultrafiltrate side, and a semipermeable membrane disposed between the blood side and the ultrafiltrate side. The ambulatory ultrafiltration also includes a buffer vessel in fluid communication with the blood side of the blood filter, and a blood pump. The blood pump is controlled to alternate between a withdrawal phase and a return phase. In the withdrawal phase, blood is withdrawn on a blood path from the subject via the blood filter to the buffer vessel. In the return phase, blood is returned from the buffer vessel to the subject on the blood path. The blood filter is arranged to remove ultrafiltrate from the blood during at least one of the withdrawal and return phases.

    摘要翻译： 动态超滤装置包括具有与受试者的血管系统血液侧或流体连通的血液过滤器，超滤液侧和设置在血液侧和超滤液侧之间的半透膜。 动态超滤还包括与血液过滤器的血液侧流体连通的缓冲容器和血液泵。 血泵被控制在戒断阶段和返回阶段之间交替。 在抽出阶段，血液在血液路径上从被检体经由血液过滤器抽出到缓冲容器。 在返回阶段，血液从血液通道从缓冲容器返回到受检者。 血液过滤器布置成在至少一个撤出和返回阶段期间从血液中除去超滤液。